Sweet's syndrome associated with granulocyte colony-stimulating factor.
Sweet's syndrome has been reported to occur in patients with malignant and inflammatory diseases. It may occur as an adverse reaction to the use of drugs, particularly the recombinant human granulocyte colony-stimulating factor (Filgrastim).
Jain
K K
KK
Drug Safety Department, Hoffmann La Roche Ltd., Basel, Switzerland.
D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D009503:Neutropenia / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects; D016463:Sweet Syndrome / Q000209:etiology*
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim